Mouse models of CNS embryonal tumors

Brain Tumor Pathology

Volumn 26, Issue 2, 2009, Pages 43-50

  Momota, Hiroyuki ^a   Holland, Eric C ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; TETRACYCLINE;

BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CYTOGENETICS; DISEASE MODEL; DNA MODIFICATION; EMBRYONAL CARCINOMA; GENETIC ENGINEERING; HISTOPATHOLOGY; HUMAN; MEDULLOBLASTOMA; MOLECULAR GENETICS; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; REVIEW; RHABDOID TUMOR; TERATOMA; TUMOR CLASSIFICATION;

ANIMALS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASMS, GERM CELL AND EMBRYONAL;

EID: 70350536643     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-009-0253-0     Document Type: Review

References (109)

1. Louis DN, Ohgaki H, Wiestler OD, et al (eds) Tumours of the central nervous system. World Health Organization Classification of Tumours. IARC, Lyon, pp 132-149
2. S.H. Bigner J. Mark H.S. Friedman J.A. Biegel, et al. 1988 Structural chromosomal abnormalities in human medulloblastoma Cancer Genet Cytogenet 30 91 101 1:STN:280:DyaL1c%2FnvF2msQ%3D%3D 3422050 (Pubitemid 18033792)
3. C.A. Griffin A.L. Hawkins R.J. Packer, et al. 1988 Chromosome abnormalities in pediatric brain tumors Cancer Res 48 175 180 1:STN:280:DyaL1c%2FotVSjsw%3D%3D 3334992
4. C.D. James J. He E. Carlbom, et al. 1990 Loss of genetic information in central nervous system tumors common to children and young adults Genes Chromosomes Cancer 2 94 102 1:STN:280:DyaK3M7itVCitg%3D%3D 1980610
5. R.L. Saylors III D. Sidransky H.S. Friedman, et al. 1991 Infrequent p53 gene mutations in medulloblastomas Cancer Res 51 4721 4723 1873817
6. P.H. Cogen L. Daneshvar A.K. Metzger, et al. 1992 Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis Am J Hum Genet 50 584 589 1:CAS:528:DyaK38XisFeit7o%3D 1347196
7. M. Badiali A. Iolascon M. Loda, et al. 1993 p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing Diagn Mol Pathol 2 23 28 1:STN:280:DyaK2c7hsFOktA%3D%3D 8287222
8. J.D. McDonald L. Daneshvar J.R. Willert, et al. 1994 Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma Genomics 23 229 232 1:CAS:528:DyaK2MXovVOlsA%3D%3D 7829075
9. D.A. Reardon E. Michalkiewicz J.M. Boyett, et al. 1997 Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization Cancer Res 57 4042 4047 1:CAS:528:DyaK2sXmtFehsbw%3D 9307291
10. J.C. Nicholson F.M. Ross J.A. Kohler, et al. 1999 Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours Br J Cancer 80 1322 1331 1:CAS:528:DyaK1MXltVWltL0%3D 10424732
11. R. Gilbertson C. Wickramasinghe R. Hernan, et al. 2001 Clinical and molecular stratification of disease risk in medulloblastoma Br J Cancer 85 705 712 1:CAS:528:DC%2BD3MXns1yktr0%3D 11531256
12. J.M. Lamont C.S. McManamy A.D. Pearson, et al. 2004 Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients Clin Cancer Res 10 5482 5493 1:CAS:528:DC%2BD2cXmvFSltb4%3D 15328187
13. B.R. Rood H. Zhang D.M. Weitman, et al. 2002 Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma Cancer Res 62 3794 3797 1:CAS:528:DC%2BD38XltF2juro%3D 12097291
14. A. Waha A. Waha A. Koch, et al. 2003 Epigenetic silencing of the HIC-1 gene in human medulloblastomas J Neuropathol Exp Neurol 62 1192 1201 1:CAS:528:DC%2BD3sXpslGntL0%3D 14656076
15. J.C. Lindsey J.A. Anderton M.E. Lusher, et al. 2005 Epigenetic events in medulloblastoma development Neurosurg Focus 19 E10 16398460
16. A.J. Frank R. Hernan A. Hollander, et al. 2004 The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma Brain Res Mol Brain Res 121 137 140 1:CAS:528: DC%2BD2cXht1yktb0%3D 14969745
17. I. Vorechovský O. Tingby M. Hartman, et al. 1997 Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours Oncogene 15 361 366 9233770
18. C. Raffel R.B. Jenkins L. Frederick, et al. 1997 Sporadic medulloblastomas contain PTCH mutations Cancer Res 57 842 845 1:CAS:528:DyaK2sXhs1Kis7c%3D 9041183
19. M. Wolter J. Reifenberger C. Sommer, et al. 1997 Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system Cancer Res 57 2581 2585 1:CAS:528:DyaK2sXkt12rtb8%3D 9205058
20. J. Reifenberger M. Wolter R.G. Weber, et al. 1998 Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system Cancer Res 58 1798 1803 1:CAS:528:DyaK1cXislensb0%3D 9581815
21. M.D. Taylor L. Liu C. Raffel C.C. Hui, et al. 2002 Mutations in SUFU predispose to medulloblastoma Nat Genet 31 306 310 1:CAS:528: DC%2BD38XkvVGmtLY%3D 12068298
22. A. Koch A. Waha W. Hartmann, et al. 2004 No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours Neuropathol Appl Neurobiol 30 532 539 1:CAS:528:DC%2BD2cXhtVektLfN 15488029
23. R.H. Zurawel S.A. Chiappa C. Allen, et al. 1998 Sporadic medulloblastomas contain oncogenic beta-catenin mutations Cancer Res 58 896 899 1:CAS:528:DyaK1cXhsFersr8%3D 9500446
24. C.G. Eberhart T. Tihan P.C. Burger 2000 Nuclear localization and mutation of beta-catenin in medulloblastomas J Neuropathol Exp Neurol 59 333 337 1:CAS:528:DC%2BD3cXisleis7c%3D 10759189
25. D.W. Ellison O.E. Onilude J.C. Lindsey, et al. 2005 Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee J Clin Oncol 23 7951 7957 1:CAS:528:DC%2BD2MXht1CqsL7P 16258095
26. D.K. Broderick C. Di T.J. Parrett, et al. 2004 Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res 64 5048 5050 1:CAS:528:DC%2BD2cXmtF2mtrk%3D 15289301
27. M.M. Inda J. Mercapide J. Muñoz, et al. 2004 PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors Oncol Rep 12 1341 1347 15547761
28. B.K. Rasheed T.T. Stenzel R.E. McLendon, et al. 1997 PTEN gene mutations are seen in high-grade but not in low-grade gliomas Cancer Res 57 4187 4190 1:CAS:528:DyaK2sXmsFChtbg%3D 9331072
29. X. Fan I. Mikolaenko I. Elhassan, et al. 2004 Notch1 and notch2 have opposite effects on embryonal brain tumor growth Cancer Res 64 7787 7793 1:CAS:528:DC%2BD2cXptFemu70%3D 15520184
30. N. Aldosari S.H. Bigner P.C. Burger, et al. 2002 MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group Arch Pathol Lab Med 126 540 544 11958658
31. C.G. Eberhart J.E. Kratz A. Schuster, et al. 2002 Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas Brain Pathol 12 36 44 1:CAS:528: DC%2BD38XlvVSmt78%3D 11770900
32. C.H. Rickert W. Paulus 2004 Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence J Neuropathol Exp Neurol 63 399 417 1:CAS:528:DC%2BD2cXlt1emurY%3D 15198120
33. J. Reifenberger G. Janssen R.G. Weber, et al. 1998 Primitive neuroectodermal tumors of the cerebral hemispheres in two siblings with TP53 germline mutation J Neuropathol Exp Neurol 57 179 187 1:CAS:528: DyaK1cXht1yksL8%3D 9600210
34. Y.S. Ho L.L. Hsieh J.S. Chen, et al. 1996 p53 gene mutation in cerebral primitive neuroectodermal tumor in Taiwan Cancer Lett 104 103 113 1:CAS:528:DyaK28Xjt1Sgt7Y%3D 8640736
35. J.A. Kraus J. Felsberg J.C. Tonn, et al. 2002 Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood Neuropathol Appl Neurobiol 28 325 333 1:CAS:528:DC%2BD38XnsVSnur0%3D 12175345
36. A. Koch A. Waha J.C. Tonn, et al. 2001 Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors Int J Cancer 93 445 449 1:CAS:528:DC%2BD3MXlt12gtr4%3D 11433413
37. C. Russo M. Pellarin O. Tingby, et al. 1999 Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors Cancer (Phila) 86 331 339 1:STN:280:DyaK1MzkslKgug%3D%3D
38. R.C. Rostomily O. Bermingham-McDonogh M.S. Berger, et al. 1997 Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors Cancer Res 57 3526 3531 1:CAS:528:DyaK2sXls1Sgsr8%3D 9270024
39. I. Versteege N. Sévenet J. Lange, et al. 1998 Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer Nature (Lond) 394 203 206 1:CAS:528:DyaK1cXksFyltr0%3D
40. J.A. Biegel J.Y. Zhou L.B. Rorke, et al. 1999 Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 74 79 1:CAS:528:DyaK1MXmsFOgsQ%3D%3D 9892189
41. J.A. Biegel L. Tan F. Zhang, et al. 2002 Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors Clin Cancer Res 8 3461 3467 1:CAS:528: DC%2BD38XpsVCgtL4%3D 12429635
42. A.R. Judkins J. Mauger A. Ht, et al. 2004 Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms Am J Surg Pathol 28 644 650 15105654
43. N. Sévenet E. Sheridan D. Amram, et al. 1999 Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers Am J Hum Genet 65 1342 1348 10521299
44. M.D. Taylor N. Gokgoz I.L. Andrulis, et al. 2000 Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene Am J Hum Genet 66 1403 1406 1:CAS:528:DC%2BD3cXntV2isL4%3D 10739763
45. J.A. Biegel 2006 Molecular genetics of atypical teratoid/rhabdoid tumor Neurosurg Focus 20 E11 16459991
46. C.W. Roberts S.H. Orkin 2004 The SWI/SNF complex: chromatin and cancer Nat Rev Cancer 4 133 142 1:CAS:528:DC%2BD2cXhtlaqu74%3D 14964309
47. R.G. Vries V. Bezrookove L.M. Zuijderduijn, et al. 2005 Cancerassociated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint Genes Dev 19 665 670 1:CAS:528: DC%2BD2MXis1Crtrs%3D 15769941
48. M.S. Isakoff C.G. Sansam P. Tamayo, et al. 2005 Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation Proc Natl Acad Sci U S A 102 17 745 17 750 1:CAS:528:DC%2BD2MXhtlegs73F
49. H.G. Brown J.L. Kepner E.J. Perlman, et al. 2000 'Large cell/anaplastic' medulloblastomas: a Pediatric Oncology Group study J Neuropathol Exp Neurol 59 857 865 1:STN:280:DC%2BD3M%2FjsVOrtw%3D%3D 11079775
50. C.G. Eberhart J.L. Kepner P.T. Goldthwaite, et al. 2002 Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study Cancer (Phila) 94 552 560
51. D. Ellison 2002 Classifying the medulloblastoma: insights from morphology and molecular genetics Neuropathol Appl Neurobiol 28 257 282 1:CAS:528:DC%2BD38XnsVSntbo%3D 12175339
52. U. Sure W.J. Berghorn H. Bertalanffy, et al. 1995 Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute Acta Neurochir (Wien) 132 59 65 1:STN:280:DyaK2M3nsVCrsw%3D%3D
53. F. Giangaspero G. Perilongo M.P. Fondelli, et al. 1999 Medulloblastoma with extensive nodularity: a variant with favorable prognosis J Neurosurg 91 971 977 1:STN:280:DC%2BD3c%2FkvFGgug%3D%3D 10584843
54. J. Bayani M. Zielenska P. Marrano, et al. 2000 Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping J Neurosurg 93 437 448 1:CAS:528:DC%2BD3cXmvVensbw%3D 10969942
55. H. Avet-Loiseau A.M. Vénuat M.J. Terrier-Lacombe, et al. 1999 Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children Br J Cancer 79 1843 1847 1:STN:280:DyaK1M3itFWnsQ%3D%3D 10206302
56. M.M. Inda C. Perot M. Guillaud-Bataille, et al. 2005 Genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumours of the central nervous system Histopathology (Oxf) 47 631 637 1:STN:280:DC%2BD2MnksV2htQ%3D%3D
57. S.B. Wharton C. Wardle J.W. Ironside, et al. 2003 Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system Neuropathol Appl Neurobiol 29 254 261 1:CAS:528:DC%2BD3sXlsFektr0%3D 12787322
58. C.H. Rickert W. Paulus 2004 Chromosomal imbalances detected by comparative genomic hybridisation in atypical teratoid/rhabdoid tumours Childs Nerv Syst 20 221 224 14767597
59. M.E. Burnett E.C. White S. Sih, et al. 1997 Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system Cancer Genet Cytogenet 97 25 31 1:CAS:528:DyaK2sXlsVGitrY%3D 9242214
60. C.G. Eberhart A. Chaudhry R.W. Daniel, et al. 2005 Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus BMC Cancer 5 19 15717928
61. M.M. Inda J. Muñoz P. Coullin, et al. 2006 High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma Histopathology (Oxf) 48 579 587 1:STN:280:DC%2BD283hslCktg%3D%3D
62. S.C. Clifford M.E. Lusher J.C. Lindsey, et al. 2006 Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis Cell Cycle 5 2666 2670 1:CAS:528:DC%2BD2sXhslyhsLY%3D 17172831
63. N. Yokota S. Nishizawa S. Ohta, et al. 2002 Role of Wnt pathway in medulloblastoma oncogenesis Int J Cancer 101 198 201 1:CAS:528: DC%2BD38XmslCksLs%3D 12209999
64. T. Pietsch A. Waha A. Koch, et al. 1997 Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched Cancer Res 57 2085 2088 1:CAS:528:DyaK2sXjslCqtbc%3D 9187099
65. R.H. Zurawel C. Allen S. Chiappa, et al. 2000 Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma Genes Chromosomes Cancer 27 44 51 1:CAS:528:DC%2BD3cXksFyr 10564585
66. J.A. Kraus C. Oster N. Sörensen, et al. 2002 Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene Neuropathol Appl Neurobiol 28 136 141 1:CAS:528: DC%2BD38XktF2qtL4%3D 11972800
67. N. Sévenet A. Lellouch-Tubiana D. Schofield, et al. 1999 Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations Hum Mol Genet 8 2359 2368 10556283
68. K.K. Frese D.A. Tuveson 2007 Maximizing mouse cancer models Nat Rev Cancer 7 645 658 1:CAS:528:DC%2BD2sXpsFSjsb8%3D 17687385
69. E.I. Fomchenko E.C. Holland 2006 Mouse models of brain tumors and their applications in preclinical trials Clin Cancer Res 12 5288 5297 1:CAS:528:DC%2BD28XpvFShs70%3D 17000661
70. O.J. Becher E.C. Holland 2006 Genetically engineered models have advantages over xenografts for preclinical studies Cancer Res 66 3355 3358 1:CAS:528:DC%2BD28XjtVOktr8%3D 16585152
71. Grisendi S, Pandolfi PP (2004) Germline modification strategies. In: Holland EC (ed) Mouse models of human cancers. Wiley, Hoboken, NJ, pp 43-65
72. P. Bates J.A. Young H.E. Varmus 1993 A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor Cell 74 1043 1051 1:CAS:528:DyaK2cXnt12rtg%3D%3D 8402880
73. J.A. Young P. Bates H.E. Varmus 1993 Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses J Virol 67 1811 1816 1:CAS:528:DyaK3sXitVKltbY%3D 8383211
74. E.C. Holland H.E. Varmus 1998 Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice Proc Natl Acad Sci U S A 95 1218 1223 1:CAS:528:DyaK1cXosFSqtw%3D%3D 9448312
75. E.C. Holland W.P. Hively R.A. DePinho, et al. 1998 A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice Genes Dev 12 3675 3685 1:CAS:528:DyaK1MXhtVantQ%3D%3D 9851974
76. L.V. Goodrich L. Milenkovi K.M. Higgins, et al. 1997 Altered neural cell fates and medulloblastoma in mouse patched mutants Science 277 1109 1113 1:CAS:528:DyaK2sXlsFSgu7o%3D 9262482
77. C. Wetmore D.E. Eberhart T. Curran 2000 The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched Cancer Res 60 2239 2246 1:CAS:528:DC%2BD3cXivVaktr8%3D 10786690
78. R.H. Zurawel C. Allen R. Wechsler-Reya, et al. 2000 Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice Genes Chromosomes Cancer 28 77 81 1:CAS:528:DC%2BD3cXis1Whtb0%3D 10738305
79. A.R. Hallahan J.I. Pritchard S. Hansen, et al. 2004 The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas Cancer Res 64 7794 7800 1:CAS:528: DC%2BD2cXptFemu7o%3D 15520185
80. H.L. Weiner R. Bakst M.S. Hurlbert, et al. 2002 Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1 Cancer Res 62 6385 6389 1:CAS:528:DC%2BD38XovFOltbc%3D 12438220
81. G. Rao C.A. Pedone C.M. Coffin, et al. 2003 c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestinexpressing neural progenitors in mice Neoplasia 5 198 204 1:CAS:528:DC%2BD3sXlvF2ltr0%3D 12869303
82. G. Rao C.A. Pedone L. Del Valle, et al. 2004 Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice Oncogene 23 6156 6162 1:CAS:528:DC%2BD2cXmsVKltb0%3D 15195141
83. S.R. Browd A.M. Kenney O.N. Gottfried, et al. 2006 N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma Cancer Res 66 2666 2672 1:CAS:528: DC%2BD28XhvV2gsrw%3D 16510586
84. T.D. McCall C.A. Pedone D.W. Fults 2007 Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehogdependent medulloblastoma formation in mice Cancer Res 67 5179 5185 1:CAS:528:DC%2BD2sXmtVaisb0%3D 17545597
85. H. Hahn L. Wojnowski K. Specht, et al. 2000 Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma J Biol Chem 275 28 341 28 344 1:CAS:528:DC%2BD3cXms1Crtbo%3D
86. K.J. Briggs I.M. Corcoran-Schwartz W. Zhang, et al. 2008 Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma Genes Dev 22 770 785 1:CAS:528:DC%2BD1cXjvFeqs78%3D 18347096
87. L.A. Donehower M. Harvey B.L. Slagle, et al. 1992 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature (Lond) 356 215 221 1:CAS:528:DyaK38XitFajsLc%3D
88. M. Harvey M.J. McArthur C.A. Montgomery Jr, et al. 1993 Genetic background alters the spectrum of tumors that develop in p53-deficient mice FASEB J 7 938 943 1:CAS:528:DyaK3sXmt1ejtro%3D 8344491
89. T. Jacks L. Remington B.O. Williams, et al. 1994 Tumor spectrum analysis in p53-mutant mice Curr Biol 4 1 7 1:CAS:528:DyaK2cXhvVygu7k%3D 7922305
90. Y. Lee P.J. McKinnon 2002 DNA ligase IV suppresses medulloblastoma formation Cancer Res 62 6395 6399 1:CAS:528:DC%2BD38XovFOlur8%3D 12438222
91. W.M. Tong H. Ohgaki H. Huang, et al. 2003 Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice Am J Pathol 162 343 352 1:CAS:528:DC%2BD3sXlsF2isw%3D%3D 12507917
92. C. Wetmore D.E. Eberhart T. Curran 2001 Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched Cancer Res 61 513 516 1:CAS:528:DC%2BD3MXht1Gms7g%3D 11212243
93. Y. Lee R. Kawagoe K. Sasai, et al. 2007 Loss of suppressor-offused function promotes tumorigenesis Oncogene 26 6442 6447 1:CAS:528: DC%2BD2sXhtV2is73O 17452975
94. C.T. Yan D. Kaushal M. Murphy, et al. 2006 XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice Proc Natl Acad Sci U S A 103 7378 7383 1:CAS:528:DC%2BD28XkslOrsLY%3D 16670198
95. P.O. Frappart Y. Lee J. Lamont, et al. 2007 BRCA2 is required for neurogenesis and suppression of medulloblastoma EMBO J 26 2732 2742 1:CAS:528:DC%2BD2sXmtFSjurw%3D 17476307
96. S. Marino M. Vooijs H. van Der Gulden, et al. 2000 Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum Genes Dev 14 994 1004 1:CAS:528:DC%2BD3cXivFyltrk%3D 10783170
97. T. Uziel F. Zindy S. Xie, et al. 2005 The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation Genes Dev 19 2656 2667 1:CAS:528:DC%2BD2MXht1ygurjO 16260494
98. F. Theuring W. Götz R. Balling, et al. 1990 Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen Oncogene 5 225 232 1:CAS:528:DyaK3cXktVerur8%3D 2157185
99. D.M. Marcus J.L. Carpenter J.M. O'Brien, et al. 1991 Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma Invest Ophthalmol Vis Sci 32 293 301 1:STN:280:DyaK3M7jtFaqsw%3D%3D 1993580
100. M.R. al-Ubaidi R.L. Font A.B. Quiambao, et al. 1992 Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter Cell Biol 119 1681 1687 1:CAS:528:DyaK3sXjs1ymtQ%3D%3D
101. C. Suri B.P. Fung A.S. Tischler, et al. 1993 Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice J Neurosci 13 1280 1291 1:CAS:528:DyaK3sXit1KhtLY%3D 7680068
102. B. Krynska J. Otte R. Franks, et al. 1999 Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals Oncogene 18 39 46 1:CAS:528:DyaK1MXhtVCnu70%3D 9926918
103. Q. Sun X. Wei J. Feng, et al. 2008 Involvement of insulin-like growth factor-insulin receptor signal pathway in the transgenic mouse model of medulloblastoma Cancer Sci 99 234 240 1:CAS:528:DC%2BD1MXjs1ygtLo%3D 18271920
104. D.L. Poulin J.A. DeCaprio 2006 Is there a role for SV40 in human cancer? J Clin Oncol 24 4356 4365 1:CAS:528:DC%2BD28XhtVGju7bO 16963733
105. D. Fults C. Pedone C. Dai, et al. 2002 MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo Neoplasia 4 32 39 1:CAS:528:DC%2BD38Xht1WltLc%3D 11922389
106. H. Momota A.H. Shih M.A. Edgar, et al. 2008 c-Myc and betacatenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice Oncogene 27 4392 4401 1:CAS:528: DC%2BD1cXovV2ksLc%3D 18372915
107. C.W. Roberts S.A. Galusha M.E. McMenamin, et al. 2000 Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice Proc Natl Acad Sci U S A 97 13 796 13 800 1:CAS:528:DC%2BD3cXoslyns7k%3D
108. A. Klochendler-Yeivin L. Fiette J. Barra, et al. 2000 The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression EMBO Rep 1 500 506 1:CAS:528:DC%2BD3MXjt1ejtLc%3D 11263494
109. C.J. Guidi A.T. Sands B.P. Zambrowicz, et al. 2001 Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice Mol Cell Biol 21 3598 3603 1:CAS:528:DC%2BD3MXjtF2jtrc%3D 11313485